Overview

A Phase 1/ Phase 2 Study of TTHX1114(NM141)

Status:
Completed

Trial end date:
2021-05-18

Target enrollment:

Participant gender:

Summary

Prospective, multicenter, randomized, masked, vehicle-controlled, dose-escalation study that includes a non-interventional observational sub-study in which subjects will undergo (standard) ocular assessments

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Trefoil Therapeutics, Inc.